1. Bassil N (2011) Late-onset hypogonadism. Med Clin North Am 95(3):507–523. https://doi.org/10.1016/j.mcna.2011.03.001
2. Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, Smith N, Sooriakumaran P, Minhas S, Wu FCW, Tomlinson J, Quinton R (2022) Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol 96(2):200–219. https://doi.org/10.1111/cen.14633
3. ‚EAU Guidelines on Sexual and Reproductive Health‘ A. Salonia (Chair), C. Bettocchi, J. Carvalho, G. Corona, T.H. Jones, A. Kadioglu, J.I. Martinez-Salamanca, S. Minhas (Vice-chair), E.C. Serefoglu, P. Verze. Guidelines Associates: L. Boeri, P. Capogrosso, A. Cocci, K. Dimitropoulos, M. Gül, G. Hatzichristodoulou, A. Kalkanli, V. Modgil, U. Milenkovic, G. Russo, T. Tharakan © European Association of Urology 2023
4. Louters M, Pearlman M, Solsrud E, Pearlman A (2022) Functional hypogonadism among patients with obesity, diabetes, and metabolic syndrome. Int J Impot Res 34(7):714–720. https://doi.org/10.1038/s41443-021-00496-7
5. Schubert M, Jockenhövel F (2005) Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects. J Endocrinol Invest 28(3 Suppl):23–27